Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.
Englund JA, Karron RA, Cunningham CK, Larussa P, Melvin A, Yogev R, Handelsman E, Siberry GK, Thumar B, Schappell E, Bull CV, Chu HY, Schaap-Nutt A, Buchholz U, Collins PL, Schmidt AC; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1096 Study Group. Englund JA, et al. Among authors: schmidt ac. Vaccine. 2013 Nov 19;31(48):5706-12. doi: 10.1016/j.vaccine.2013.09.046. Epub 2013 Oct 5. Vaccine. 2013. PMID: 24103895 Free PMC article. Clinical Trial.
Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products.
Gombold J, Karakasidis S, Niksa P, Podczasy J, Neumann K, Richardson J, Sane N, Johnson-Leva R, Randolph V, Sadoff J, Minor P, Schmidt A, Duncan P, Sheets RL. Gombold J, et al. Vaccine. 2014 May 19;32(24):2916-26. doi: 10.1016/j.vaccine.2014.02.021. Epub 2014 Mar 25. Vaccine. 2014. PMID: 24681273 Free PMC article.
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
Kochhar S, Barreira D, Beattie P, Cavaleri M, Cravioto A, Frick MW, Ginsberg AM, Hudson I, Kaslow DC, Kurtz S, Lienhardt C, Madhi SA, Morgan C, Momeni Y, Patel D, Rees H, Rogalski-Salter T, Schmidt A, Semete-Makokotlela B, Voss G, White RG, Zignol M, Giersing B. Kochhar S, et al. Vaccine. 2022 Mar 15;40(12):1681-1690. doi: 10.1016/j.vaccine.2021.10.062. Epub 2022 Feb 11. Vaccine. 2022. PMID: 35164990 Free PMC article.
The quest for vaccine-induced immune correlates of protection against tuberculosis.
Nemes E, Fiore-Gartland A, Boggiano C, Coccia M, D'Souza P, Gilbert P, Ginsberg A, Hyrien O, Laddy D, Makar K, McElrath MJ, Ramachandra L, Schmidt AC, Shororbani S, Sunshine J, Tomaras G, Yu WH, Scriba TJ, Frahm N; BCG Correlates PIs Study Team, M72 Correlates PIs Study Team. Nemes E, et al. Among authors: schmidt ac. Vaccine Insights. 2022 Jul;1(3):165-181. doi: 10.18609/vac/2022.027. Epub 2022 Jul 29. Vaccine Insights. 2022. PMID: 37091190 Free PMC article.
Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine development.
Looney MM, Hatherill M, Musvosvi M, Flynn J, Kagina BM, Frick M, Kafuko Z, Schmidt A, Southern J, Wilder-Smith A, Tippoo P, Paradkar V, Popadić D, Scriba TJ, Hanekom W, Giersing B. Looney MM, et al. Vaccine. 2023 Nov 22;41(48):7060-7066. doi: 10.1016/j.vaccine.2023.10.026. Epub 2023 Oct 21. Vaccine. 2023. PMID: 37872013 Free article.
Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.
Dos Santos G, Nguyen BY, Damaso S, Godderis L, Martínez-Gómez X, Eckermann T, Loos H, Salamanca de la Cueva I, Shende V, Schmidt AC, Yeakey A. Dos Santos G, et al. Among authors: schmidt ac. Drug Saf. 2020 Mar;43(3):265-279. doi: 10.1007/s40264-019-00893-4. Drug Saf. 2020. PMID: 31884676 Free PMC article.
New hope for tuberculosis vaccines.
Olesen OF, Abdullah F, Coppens R, Gardner PJ, Ginsberg AM, Hanekom WA, Laang H, Lewinsohn DM, Loots G, Schmidt A, Vekemans J, Voss GH. Olesen OF, et al. Lancet Infect Dis. 2019 Jul;19(7):687-688. doi: 10.1016/S1473-3099(19)30280-4. Lancet Infect Dis. 2019. PMID: 31250810 No abstract available.
160 results